Company: PAVS
Filing Date: 2025-11-25
Form Type: F-3
Source: 0001929980-25-000743
Chunk: 14

Company: Paranovus Entertainment Technology Ltd.
Filing Date: 2025-11-25
Form: F-3
Chunk 14
---
 Amended and Restated Notes are extended to March 31, 2026.

On October 28, 2025, the Company entered into a certain sales agreement with A.G.P/Alliance Global Partners (the “Sales Agent”) to issue and sell Company’s Class A ordinary shares, par value $0.01 per share, from time to time, through an at the market offering under which the Sales Agent will act as sales agent and/or principal. In connection with this sales agreement, the Company filed a prospectus supplement to offer up to an aggregate of 166,666,667 Class A ordinary shares, par value $0.01 per share, having an aggregate offering price of up to $100,000,000 from time to time through or to A.G.P. as sales agent or principal.

The following chart illustrates our corporate structure as of the date of this prospectus, showing the Company’s principal subsidiaries, together with the jurisdiction of incorporation of each company and the percentage of voting securities beneficially owned, controlled or directed, directly or indirectly, by the Company.

| * | unless otherwise indicated, the percentage of the voting power is 100% in the chart above. |

| 8 |

The Company is subject to the informational requirements of the Securities Exchange Act of 1934, as amended, and will file reports, registration statements and other information with the SEC. The Company’s reports, registration statements and other information can be inspected on the SEC’s website at www.sec.gov. You may also visit us at https://pavs.ai. However, information contained on our website does not constitute a part of this prospectus.

Business Overview

We are a holding company incorporated in Cayman Islands with no material operations of our own. Currently, our operation is conducted through our wholly owned subsidiary, 2Lab3 and 51% owned subsidiary, BW, in the U.S. Historically, through our operating subsidiaries in the PRC, we engaged in the (i) nutraceutical and dietary supplements business (divested in August 2023), (ii) e-commerce business (suspended in September 2023), (iii) internet information and advertising business (suspended in September 2023) and (iv) automobile sale business (divested in July 2024).

In March 2023, we consummated an acquisition of 100% of 2lab3, through which, we expanded our business into the AI and entertainment industries. On March 25, 2025